Mode
Text Size
Log in / Sign up
N/A Completed N=30 Other

ANNE Diagnostic Agreement With Home Sleep Testing

Obstructive Sleep Apnea of Adult
Source: ClinicalTrials.gov NCT05421754 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
May 2023
Primary outcomePrimary: Percent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea. — 58; 75 percent agreement

Summary

The main objective of this study is to provide an adequately powered study that would provide evidence on the non-inferiority of ANNE to a Home Sleep Test (HST).

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea.
58; 75

Eligibility Criteria

Inclusion Criteria

  • 22 years old.
  • Subjects with suspected OSA based on history and physical. Subjects with self-reported symptoms of OSA based on the STOP-Bang questionnaire indicating affirmative answers to any of the following: snoring, daytime fatigue/sleepiness/tiredness, partners who have observed the subject stopping breathing or choking/gasping during sleep. Persons with a previous diagnosis of OSA are also eligible.
  • Willingness to give written consent and comply with study procedures

Exclusion Criteria

-An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related to this trial or interferes with the clinical trial and data collection based on the opinion of the investigator, this includes but is not limited to: A. Significant cardiorespiratory disease: patients that are oxygen dependent, previous hospitalization for cardiorespiratory issues, or left ventricular ejection fraction ≤ to 40% B. Respiratory muscle weakness due to a neuromuscular condition C. Awake hypoventilation or suspicion of sleep related hypoventilation D. Chronic opioid medication use E. History of stroke F. History of severe insomnia

  • Inability to understand instructions
  • Has a skin abnormality that precludes assessment
  • Has a history of dementia
  • Patients with implanted pacemakers or defibrillators
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05421754). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search